ACETAMINOPHEN, DEXTROMETHORPHAN HBR

ACETAMINOPHEN, DEXTROMETHORPHAN HBR was reported 4193 times

ACETAMINOPHEN, DEXTROMETHORPHAN HBR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULAR LYMPHOMA REFRACTORY 5 0.0769
1 URETERIC HAEMORRHAGE 5 0.0725
2 TESTICULAR OPERATION 4 0.0714
3 GRIP STRENGTH 13 0.0568
4 DENGUE HAEMORRHAGIC FEVER 3 0.0469
5 NASAL HERPES 8 0.0394
6 HEPATIC ENZYME 5 0.0336
7 HYPOAESTHESIA EYE 19 0.0322
8 ACTION TREMOR 5 0.0309
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 20 0.0299
10 FOETAL CHROMOSOME ABNORMALITY 5 0.0294
11 STEROID DEPENDENCE 23 0.0262
12 REDUCED FACIAL EXPRESSION 26 0.0256
13 DEEP VEIN THROMBOSIS POSTOPERATIVE 49 0.0245
14 CATARRH 22 0.0243
15 LUPUS VULGARIS 29 0.0230
16 C-REACTIVE PROTEIN 21 0.0227
17 FACET JOINT SYNDROME 70 0.0215
18 RHEUMATIC FEVER 90 0.0202
19 SWOLLEN JOINT COUNT INCREASED 64 0.0201
20 SWOLLEN JOINT COUNT 5 0.0200
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 11 0.0196
22 MERALGIA PARAESTHETICA 4 0.0190
23 X-RAY ABNORMAL 33 0.0184
24 NEUROLOGIC NEGLECT SYNDROME 10 0.0180
25 TRANSFERRIN SATURATION DECREASED 7 0.0164
26 DUODENAL ULCER PERFORATION 120 0.0161
27 NIPPLE SWELLING 4 0.0159
28 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 33 0.0159
29 PERIPHERAL VENOUS DISEASE 60 0.0147
30 RETINITIS 25 0.0145
31 DISLOCATION OF VERTEBRA 33 0.0145
32 MEAN PLATELET VOLUME DECREASED 12 0.0143
33 HYPOCHOLESTEROLAEMIA 5 0.0142
34 GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0140
35 ABDOMINAL LYMPHADENOPATHY 12 0.0138
36 AUTOIMMUNE NEPHRITIS 3 0.0136
37 NEUTROPENIC INFECTION 13 0.0136
38 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 95 0.0132
39 ANTIPSYCHOTIC DRUG LEVEL DECREASED 7 0.0132
40 RHEUMATOID FACTOR POSITIVE 74 0.0128
41 BLISTER INFECTED 10 0.0128
42 PORPHYRIA ACUTE 18 0.0125
43 BURNS SECOND DEGREE 22 0.0125
44 MUSCLE INJURY 103 0.0124
45 MONOCYTE COUNT DECREASED 15 0.0123
46 C-REACTIVE PROTEIN DECREASED 8 0.0123
47 HELICOBACTER INFECTION 124 0.0121
48 FOLLICULITIS 126 0.0120
49 CAROTID ARTERY THROMBOSIS 10 0.0118
50 C-REACTIVE PROTEIN ABNORMAL 74 0.0115
51 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 74 0.0114
52 IMMUNODEFICIENCY COMMON VARIABLE 5 0.0102
53 LISTLESS 33 0.0100
54 PEMPHIGUS 125 0.0100
55 HAND DEFORMITY 128 0.0097
56 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
57 ALCOHOL POISONING 23 0.0086
58 PERICARDITIS 139 0.0083
59 LIP DRY 74 0.0081
60 ONYCHOMADESIS 34 0.0081
61 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
62 ONYCHOMYCOSIS 35 0.0080
63 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 13 0.0078
64 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 5 0.0078
65 ADJUSTMENT DISORDER 10 0.0077
66 VESTIBULAR NEURONITIS 4 0.0075
67 HYPERCHOLESTEROLAEMIA 72 0.0074
68 BREAST CANCER STAGE III 48 0.0074
69 SYNOVITIS 130 0.0072
70 JOINT RANGE OF MOTION DECREASED 88 0.0066
71 HYPOPNOEA 22 0.0063
72 GRIP STRENGTH DECREASED 55 0.0062
73 BONE EROSION 22 0.0062
74 ARTERIOVENOUS FISTULA 3 0.0061
75 BURSITIS 72 0.0059
76 STREPTOCOCCAL SEPSIS 7 0.0059
77 GLOSSODYNIA 128 0.0057
78 FACIAL DISCOMFORT 4 0.0056
79 IRRITABLE BOWEL SYNDROME 119 0.0055
80 WOUND INFECTION 60 0.0055
81 CHIKUNGUNYA VIRUS INFECTION 3 0.0054
82 LIVE BIRTH 44 0.0053
83 AUTOIMMUNE DISORDER 49 0.0050
84 WOUND 137 0.0049
85 IMMOBILE 21 0.0048
86 MATERNAL EXPOSURE TIMING UNSPECIFIED 18 0.0048
87 SYSTEMIC LUPUS ERYTHEMATOSUS 170 0.0048
88 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
89 MEDICATION OVERUSE HEADACHE 4 0.0047
90 GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0045
91 FOREIGN BODY 18 0.0045
92 FACIAL SPASM 5 0.0045
93 VULVOVAGINAL CANDIDIASIS 6 0.0044
94 FIBROMYALGIA 104 0.0043
95 BLEPHAROSPASM 26 0.0041
96 PRODUCT LABEL CONFUSION 24 0.0041
97 IMPAIRED HEALING 135 0.0041
98 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
99 OBESITY 65 0.0041
100 BRAIN STEM SYNDROME 3 0.0040
101 LIVER INJURY 98 0.0040
102 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
103 PERIARTHRITIS 9 0.0040
104 TROPONIN T INCREASED 5 0.0039
105 PARAINFLUENZAE VIRUS INFECTION 6 0.0039
106 EYE COLOUR CHANGE 4 0.0039
107 SCIATICA 61 0.0038
108 PERSONALITY DISORDER 10 0.0038
109 SYSTOLIC DYSFUNCTION 4 0.0038
110 TUMOUR PAIN 5 0.0038
111 FINGER DEFORMITY 18 0.0037
112 URETERIC OBSTRUCTION 5 0.0037
113 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
114 METABOLIC SYNDROME 6 0.0036
115 AFFECT LABILITY 35 0.0036
116 NAIL DISORDER 31 0.0035
117 RED BLOOD CELL SEDIMENTATION RATE INCREASED 39 0.0035
118 TYPE 2 DIABETES MELLITUS 118 0.0035
119 SERONEGATIVE ARTHRITIS 4 0.0035
120 PELVIC FRACTURE 27 0.0035
121 BRONCHIECTASIS 23 0.0034
122 LOWER RESPIRATORY TRACT INFECTION 149 0.0033
123 LIVER FUNCTION TEST INCREASED 69 0.0032
124 PAROSMIA 24 0.0032
125 TESTICULAR SWELLING 4 0.0032
126 RHINITIS 25 0.0031
127 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
128 STOMA SITE INFECTION 4 0.0031
129 LOWER LIMB FRACTURE 58 0.0030
130 GINGIVAL PAIN 24 0.0030
131 EYE INJURY 9 0.0030
132 PSORIATIC ARTHROPATHY 120 0.0030
133 PUSTULAR PSORIASIS 10 0.0029
134 RASH VESICULAR 14 0.0029
135 HYPOPITUITARISM 5 0.0029
136 COELIAC DISEASE 28 0.0029
137 HYPERKINESIA 6 0.0028
138 CARDIAC MURMUR 24 0.0028
139 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 17 0.0027
140 EXOSTOSIS 25 0.0027
141 DELIRIUM 95 0.0027
142 APATHY 39 0.0027
143 GAIT INABILITY 89 0.0027
144 PULMONARY FIBROSIS 50 0.0026
145 PRESCRIBED OVERDOSE 50 0.0026
146 C-REACTIVE PROTEIN INCREASED 94 0.0026
147 WALKING AID USER 17 0.0026
148 NORMAL NEWBORN 14 0.0026
149 DRUG TOLERANCE DECREASED 7 0.0025
150 VASOPLEGIA SYNDROME 4 0.0024
151 INFUSION RELATED REACTION 161 0.0024
152 HYPERPARATHYROIDISM 5 0.0024
153 BLOOD CHOLESTEROL INCREASED 111 0.0024
154 BAND SENSATION 3 0.0024
155 JOINT DISLOCATION 25 0.0024
156 MYOSITIS 21 0.0023
157 SERUM FERRITIN DECREASED 4 0.0023
158 BACK INJURY 25 0.0023
159 CONTRAINDICATED PRODUCT ADMINISTERED 68 0.0022
160 ULCER HAEMORRHAGE 15 0.0022
161 CUSHINGOID 7 0.0022
162 CALCIPHYLAXIS 4 0.0022
163 NIGHT SWEATS 70 0.0022
164 HEMIPLEGIA 18 0.0022
165 OSTEOARTHRITIS 91 0.0021
166 HEPATIC ENZYME INCREASED 146 0.0021
167 STOMA SITE ERYTHEMA 4 0.0021
168 ARTHROPATHY 119 0.0021
169 CHRONIC SINUSITIS 8 0.0021
170 ALVEOLITIS 3 0.0021
171 BLISTER 119 0.0021
172 OROPHARYNGEAL DISCOMFORT 19 0.0021
173 MOBILITY DECREASED 151 0.0021
174 FOOT DEFORMITY 23 0.0021
175 SCHIZOPHRENIA 25 0.0021
176 DISCOMFORT 125 0.0020
177 BREAST CANCER STAGE II 17 0.0020
178 GANGRENE 12 0.0020
179 HEAD DISCOMFORT 35 0.0020
180 IMMUNE-MEDIATED HEPATITIS 4 0.0020
181 SPONDYLITIS 7 0.0019
182 NIGHTMARE 66 0.0019
183 ILL-DEFINED DISORDER 115 0.0019
184 RECALLED PRODUCT ADMINISTERED 18 0.0019
185 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
186 LUPUS-LIKE SYNDROME 17 0.0019
187 ABSCESS INTESTINAL 4 0.0019
188 STOMA SITE DISCHARGE 5 0.0018
189 IMMUNODEFICIENCY 27 0.0018
190 INJURY 127 0.0018
191 FAECES PALE 4 0.0018
192 LIVER DISORDER 79 0.0018
193 STOMATITIS 107 0.0018
194 GENERAL PHYSICAL HEALTH DETERIORATION 202 0.0017
195 EMOTIONAL POVERTY 3 0.0017
196 WHEEZING 101 0.0017
197 SWELLING 159 0.0017
198 IMPAIRED QUALITY OF LIFE 24 0.0017
199 INFLAMMATION 86 0.0017
200 CEREBROVASCULAR DISORDER 5 0.0017
201 BONE MARROW DISORDER 5 0.0017
202 HEPATIC CIRRHOSIS 31 0.0016
203 PREGNANCY 33 0.0016
204 UTERINE LEIOMYOMA 12 0.0016
205 SLEEP DISORDER 115 0.0016
206 RETROPERITONEAL HAEMORRHAGE 4 0.0016
207 SENSORY LOSS 13 0.0016
208 INFLAMMATORY MARKER INCREASED 8 0.0016
209 BLOOD IRON DECREASED 19 0.0016
210 SQUAMOUS CELL CARCINOMA 15 0.0016
211 FREQUENT BOWEL MOVEMENTS 43 0.0016
212 CONFUSIONAL STATE 257 0.0016
213 MOTOR DYSFUNCTION 16 0.0016
214 URINARY RETENTION 52 0.0016
215 LUNG DISORDER 76 0.0015
216 MUSCULOSKELETAL PAIN 81 0.0015
217 SPINAL CORD COMPRESSION 6 0.0015
218 ABDOMINAL WALL HAEMATOMA 3 0.0015
219 TASTE DISORDER 31 0.0015
220 BEDRIDDEN 20 0.0015
221 VITAMIN D DECREASED 13 0.0015
222 MUSCULOSKELETAL STIFFNESS 132 0.0015
223 CEREBRAL ATROPHY 6 0.0015
224 POOR QUALITY SLEEP 32 0.0015
225 OEDEMA 80 0.0015
226 NEUTROPHIL COUNT INCREASED 15 0.0015
227 PRESCRIBED UNDERDOSE 29 0.0015
228 LEFT VENTRICULAR FAILURE 5 0.0015
229 SEDATION 38 0.0014
230 CONTUSION 139 0.0014
231 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
232 ROAD TRAFFIC ACCIDENT 60 0.0014
233 PROCTITIS 4 0.0014
234 DILATATION VENTRICULAR 3 0.0014
235 RHEUMATOID ARTHRITIS 162 0.0014
236 GASTROINTESTINAL DISORDER 127 0.0014
237 JAUNDICE CHOLESTATIC 5 0.0014
238 UROSEPSIS 13 0.0014
239 CARDIAC FAILURE CHRONIC 6 0.0014
240 ABSCESS LIMB 6 0.0014
241 FIBRIN D DIMER INCREASED 5 0.0014
242 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
243 PYODERMA GANGRENOSUM 5 0.0014
244 MUSCLE SPASTICITY 17 0.0014
245 JOINT SWELLING 164 0.0014
246 THORACIC VERTEBRAL FRACTURE 4 0.0014
247 FREEZING PHENOMENON 5 0.0013
248 PERIORBITAL OEDEMA 7 0.0013
249 GENERAL SYMPTOM 10 0.0013
250 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
251 MEDICATION ERROR 74 0.0013
252 DRY MOUTH 108 0.0013
253 HEPATIC NECROSIS 5 0.0013
254 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
255 TROPONIN INCREASED 10 0.0013
256 DENGUE FEVER 3 0.0013
257 DRUG-INDUCED LIVER INJURY 41 0.0013
258 LOCALISED OEDEMA 6 0.0013
259 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
260 RHINOVIRUS INFECTION 5 0.0013
261 ADVERSE REACTION 17 0.0013
262 BLOOD CREATININE DECREASED 4 0.0013
263 LIVER FUNCTION TEST ABNORMAL 37 0.0013
264 TESTICULAR PAIN 4 0.0013
265 NEUTROPENIC SEPSIS 9 0.0013
266 POLYMYALGIA RHEUMATICA 4 0.0013
267 LYMPHOCYTE COUNT DECREASED 22 0.0012
268 HAEMOGLOBIN ABNORMAL 8 0.0012
269 NEUROLOGICAL SYMPTOM 7 0.0012
270 ANAL INCONTINENCE 11 0.0012
271 DERMAL CYST 3 0.0012
272 ENCEPHALOPATHY 30 0.0012
273 MYOCARDITIS 14 0.0012
274 OTITIS MEDIA 4 0.0012
275 CONGESTIVE CARDIOMYOPATHY 5 0.0012
276 RECTAL HAEMORRHAGE 51 0.0012
277 BRADYKINESIA 7 0.0012
278 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
279 THERAPEUTIC PRODUCT EFFECT DECREASED 53 0.0012
280 VERTIGO 72 0.0012
281 HEPATIC CYST 4 0.0012
282 PNEUMONITIS 32 0.0012
283 EXPOSURE DURING PREGNANCY 73 0.0012
284 CANCER PAIN 3 0.0012
285 FACIAL PARALYSIS 10 0.0012
286 HEPATITIS 30 0.0012
287 FEMORAL NECK FRACTURE 6 0.0012
288 FOOD ALLERGY 9 0.0012
289 INTENTIONAL PRODUCT USE ISSUE 102 0.0012
290 PLATELET COUNT INCREASED 15 0.0011
291 COMPARTMENT SYNDROME 3 0.0011
292 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
293 CHOLANGITIS 7 0.0011
294 MATERNAL EXPOSURE DURING PREGNANCY 100 0.0011
295 OVERWEIGHT 6 0.0011
296 IRON DEFICIENCY 5 0.0011
297 HIP ARTHROPLASTY 17 0.0011
298 HYPERTENSION 235 0.0011
299 SINUSITIS 113 0.0011
300 KNEE ARTHROPLASTY 23 0.0011
301 HYPOMANIA 4 0.0011
302 PERFORMANCE STATUS DECREASED 5 0.0011
303 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
304 FRACTURE 20 0.0011
305 MIGRAINE 100 0.0010
306 CLAVICLE FRACTURE 4 0.0010
307 BLOOD URIC ACID INCREASED 6 0.0010
308 RESTLESSNESS 38 0.0010
309 COMA SCALE ABNORMAL 3 0.0010
310 THROAT TIGHTNESS 28 0.0010
311 CONGENITAL ANOMALY 8 0.0010
312 RALES 6 0.0010
313 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
314 HYPONATRAEMIA 58 0.0010
315 SPLENOMEGALY 12 0.0010
316 EPILEPSY 31 0.0010
317 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
318 HAEMATOCRIT DECREASED 20 0.0010
319 BLADDER DISORDER 10 0.0010
320 INJECTION SITE INFLAMMATION 5 0.0010
321 HYPERAMMONAEMIA 5 0.0010
322 BLEPHARITIS 4 0.0010
323 ABDOMINAL DISCOMFORT 167 0.0010
324 HYPOAESTHESIA 149 0.0010
325 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
326 HYPERSENSITIVITY 184 0.0010
327 COLITIS ULCERATIVE 44 0.0010
328 EAR INFECTION 26 0.0010
329 IRON DEFICIENCY ANAEMIA 9 0.0010
330 SELF-MEDICATION 4 0.0010
331 INFECTION 140 0.0010
332 FOETAL DEATH 5 0.0010
333 HAEMOGLOBIN DECREASED 99 0.0010
334 SINUS CONGESTION 13 0.0010
335 SWOLLEN TONGUE 30 0.0010
336 BLOOD BLISTER 3 0.0010
337 PALLOR 26 0.0010
338 NECK PAIN 53 0.0009
339 SKIN HAEMORRHAGE 14 0.0009
340 HEMIPARESIS 16 0.0009
341 RED BLOOD CELL COUNT DECREASED 27 0.0009
342 PYREXIA 325 0.0009
343 HERNIA 18 0.0009
344 STRESS FRACTURE 5 0.0009
345 OXYGEN SATURATION DECREASED 52 0.0009
346 BACK DISORDER 15 0.0009
347 COGNITIVE DISORDER 43 0.0009
348 BOWEL MOVEMENT IRREGULARITY 7 0.0009
349 INTESTINAL ISCHAEMIA 5 0.0009
350 PARAESTHESIA ORAL 13 0.0009
351 CYTOKINE RELEASE SYNDROME 18 0.0009
352 EMPHYSEMA 9 0.0009
353 IMPAIRED WORK ABILITY 19 0.0009
354 POSTOPERATIVE WOUND INFECTION 6 0.0009
355 RESPIRATORY TRACT CONGESTION 14 0.0009
356 DRUG INTOLERANCE 85 0.0009
357 NEUTROPHILIA 5 0.0009
358 LUMBAR VERTEBRAL FRACTURE 4 0.0009
359 NASOPHARYNGITIS 160 0.0009
360 BLOOD CREATININE ABNORMAL 3 0.0009
361 HYPOKALAEMIA 40 0.0009
362 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
363 RENAL FUNCTION TEST ABNORMAL 4 0.0009
364 AORTIC STENOSIS 3 0.0009
365 METABOLIC DISORDER 5 0.0009
366 COORDINATION ABNORMAL 12 0.0009
367 FEBRILE NEUTROPENIA 57 0.0009
368 HYPOVOLAEMIA 5 0.0009
369 INCONTINENCE 9 0.0009
370 ACCIDENTAL OVERDOSE 31 0.0008
371 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
372 JOINT STIFFNESS 22 0.0008
373 BREAST CANCER METASTATIC 9 0.0008
374 ANGINA PECTORIS 24 0.0008
375 PERIPHERAL SWELLING 129 0.0008
376 OEDEMA PERIPHERAL 102 0.0008
377 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
378 TUMOUR MARKER INCREASED 4 0.0008
379 BODY TEMPERATURE INCREASED 17 0.0008
380 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
381 INGUINAL HERNIA 5 0.0008
382 ORAL HERPES 16 0.0008
383 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
384 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
385 AMNESIA 53 0.0008
386 ARTHRITIS 64 0.0008
387 ALCOHOL USE 3 0.0008
388 AMYLASE INCREASED 3 0.0008
389 MYOPATHY 7 0.0008
390 FOOT OPERATION 4 0.0008
391 DYSPEPSIA 79 0.0008
392 HEPATIC ENZYME ABNORMAL 4 0.0008
393 TREATMENT FAILURE 66 0.0008
394 ERYSIPELAS 4 0.0008
395 CORONARY ARTERY STENOSIS 4 0.0008
396 VULVOVAGINAL PRURITUS 4 0.0008
397 LETHARGY 45 0.0008
398 THERAPY NON-RESPONDER 35 0.0008
399 OSTEOPOROSIS 32 0.0008
400 MUSCULOSKELETAL CHEST PAIN 12 0.0008
401 EAR PAIN 15 0.0008
402 SKIN NECROSIS 4 0.0008
403 TONSILLITIS 4 0.0008
404 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
405 MUSCULAR WEAKNESS 87 0.0008
406 URTICARIA 128 0.0008
407 HYPOGAMMAGLOBULINAEMIA 5 0.0008
408 HYPERTHYROIDISM 11 0.0008
409 ORAL CANDIDIASIS 10 0.0008
410 POLYARTHRITIS 4 0.0008
411 DISABILITY 15 0.0008
412 SERUM FERRITIN INCREASED 4 0.0008
413 DECREASED APPETITE 175 0.0008
414 MALIGNANT MELANOMA 10 0.0007
415 POST-TRAUMATIC STRESS DISORDER 5 0.0007
416 HAEMATOCHEZIA 41 0.0007
417 RESPIRATORY DISORDER 22 0.0007
418 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
419 ARTHRITIS BACTERIAL 3 0.0007
420 EYE MOVEMENT DISORDER 5 0.0007
421 ECCHYMOSIS 5 0.0007
422 ALOPECIA 143 0.0007
423 ACUTE CORONARY SYNDROME 6 0.0007
424 DIVERTICULITIS 20 0.0007
425 ASTHMA 81 0.0007
426 PAIN IN EXTREMITY 210 0.0007
427 URINARY INCONTINENCE 21 0.0007
428 APHASIA 21 0.0007
429 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
430 MOUTH SWELLING 4 0.0007
431 DYSARTHRIA 26 0.0007
432 ATRIAL FIBRILLATION 67 0.0007
433 WEIGHT INCREASED 154 0.0007
434 DYSPHEMIA 3 0.0007
435 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
436 SPINAL PAIN 8 0.0007
437 CHEST PAIN 126 0.0007
438 IMMUNOSUPPRESSION 6 0.0007
439 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
440 FACIAL PAIN 6 0.0007
441 METASTASES TO BONE 11 0.0007
442 HYPERHIDROSIS 86 0.0007
443 HAEMORRHOIDS 13 0.0007
444 MOUTH ULCERATION 14 0.0007
445 RENAL PAIN 7 0.0007
446 NEURALGIA 16 0.0007
447 EATING DISORDER 14 0.0007
448 SINUS DISORDER 13 0.0007
449 HAEMATOMA 17 0.0007
450 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
451 NERVE COMPRESSION 6 0.0006
452 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
453 CONDITION AGGRAVATED 197 0.0006
454 ARTHRITIS INFECTIVE 3 0.0006
455 LIMB DISCOMFORT 20 0.0006
456 PHARYNGITIS 8 0.0006
457 APPENDICITIS 6 0.0006
458 AFFECTIVE DISORDER 5 0.0006
459 RIB FRACTURE 13 0.0006
460 TINNITUS 29 0.0006
461 BLOOD ALBUMIN DECREASED 5 0.0006
462 HEPATIC FAILURE 19 0.0006
463 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
464 PANCREATITIS 33 0.0006
465 SNEEZING 14 0.0006
466 ATELECTASIS 6 0.0006
467 CHROMATURIA 14 0.0006
468 ABDOMINAL PAIN UPPER 127 0.0006
469 HEPATITIS ACUTE 4 0.0006
470 ASPHYXIA 5 0.0006
471 POLYP 4 0.0006
472 SUICIDE ATTEMPT 37 0.0006
473 ESCHERICHIA INFECTION 5 0.0006
474 COLITIS 23 0.0006
475 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
476 CHILLS 71 0.0006
477 ABDOMINAL TENDERNESS 3 0.0006
478 HYPOACUSIS 26 0.0006
479 PULMONARY OEDEMA 27 0.0006
480 PNEUMONIA 195 0.0006
481 SKIN MASS 4 0.0006
482 SPINAL FRACTURE 12 0.0006
483 ANXIETY 170 0.0006
484 MOOD SWINGS 19 0.0006
485 METASTASES TO LYMPH NODES 4 0.0006
486 DYSLIPIDAEMIA 3 0.0006
487 HEPATIC STEATOSIS 11 0.0006
488 NEPHROLITHIASIS 27 0.0006
489 PHOTOPHOBIA 11 0.0006
490 DEEP VEIN THROMBOSIS 38 0.0006
491 PARAESTHESIA 92 0.0006
492 HAEMATURIA 20 0.0006
493 TEMPERATURE INTOLERANCE 6 0.0006
494 HYPOCALCAEMIA 11 0.0006
495 RESPIRATION ABNORMAL 4 0.0006
496 TOOTH LOSS 12 0.0006
497 MUSCLE STRAIN 5 0.0006
498 VENTRICULAR EXTRASYSTOLES 6 0.0006
499 DIPLOPIA 15 0.0006
500 PRODUCT USE IN UNAPPROVED INDICATION 143 0.0006
501 ACUTE MYOCARDIAL INFARCTION 17 0.0006
502 APLASTIC ANAEMIA 3 0.0006
503 TACHYCARDIA 51 0.0006
504 PALPITATIONS 67 0.0006
505 ABDOMINAL PAIN 133 0.0006
506 RESPIRATORY DEPRESSION 7 0.0006
507 DYSURIA 21 0.0006
508 BLOOD CALCIUM INCREASED 5 0.0006
509 BLOOD LACTIC ACID INCREASED 3 0.0006
510 SPINAL OSTEOARTHRITIS 5 0.0006
511 PULMONARY EMBOLISM 54 0.0006
512 FALL 189 0.0006
513 HYPERCALCAEMIA 7 0.0006
514 LYMPHOPENIA 8 0.0006
515 CHOKING 11 0.0006
516 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
517 BONE PAIN 33 0.0006
518 RETCHING 12 0.0006
519 DEHYDRATION 75 0.0006
520 MUSCLE SPASMS 103 0.0006
521 SENSORY DISTURBANCE 9 0.0006
522 HEREDITARY ANGIOEDEMA 6 0.0006
523 ECZEMA 29 0.0006
524 MALAISE 243 0.0006
525 DERMATITIS BULLOUS 4 0.0006
526 RASH 240 0.0006
527 OPTIC NEURITIS 5 0.0005
528 DEPRESSION 125 0.0005
529 VOMITING 258 0.0005
530 BLOOD GLUCOSE FLUCTUATION 6 0.0005
531 ARTHRALGIA 227 0.0005
532 AUTISM SPECTRUM DISORDER 3 0.0005
533 NERVOUS SYSTEM DISORDER 17 0.0005
534 ASCITES 16 0.0005
535 PAIN 334 0.0005
536 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
537 OVARIAN CANCER 5 0.0005
538 CARDIOMYOPATHY 8 0.0005
539 NERVE INJURY 6 0.0005
540 MEMORY IMPAIRMENT 74 0.0005
541 SKIN INFECTION 6 0.0005
542 BLOOD CALCIUM DECREASED 6 0.0005
543 FLANK PAIN 5 0.0005
544 GAIT DISTURBANCE 102 0.0005
545 HYPOAESTHESIA ORAL 8 0.0005
546 INTENTIONAL OVERDOSE 34 0.0005
547 DYSPNOEA 300 0.0005
548 MOVEMENT DISORDER 17 0.0005
549 INSOMNIA 140 0.0005
550 DYSGEUSIA 39 0.0005
551 ABORTION SPONTANEOUS 21 0.0005
552 LIPASE INCREASED 4 0.0005
553 FEELING HOT 32 0.0005
554 THROMBOCYTOPENIA 58 0.0005
555 CHEST DISCOMFORT 53 0.0005
556 SINUS BRADYCARDIA 5 0.0005
557 FEMUR FRACTURE 16 0.0005
558 ELECTROLYTE IMBALANCE 6 0.0005
559 CELLULITIS 26 0.0005
560 LUNG INFECTION 8 0.0005
561 BASAL CELL CARCINOMA 8 0.0005
562 PHARYNGEAL SWELLING 5 0.0005
563 GASTROINTESTINAL INFLAMMATION 4 0.0005
564 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
565 HEPATOMEGALY 5 0.0005
566 INJECTION SITE REACTION 35 0.0005
567 ABDOMINAL DISTENSION 53 0.0005
568 HEADACHE 316 0.0005
569 RENAL CYST 4 0.0005
570 TRICUSPID VALVE INCOMPETENCE 4 0.0005
571 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
572 FEELING COLD 14 0.0005
573 CYSTITIS 16 0.0005
574 HYPERLIPIDAEMIA 6 0.0005
575 GOUT 9 0.0005
576 BLOOD DISORDER 4 0.0005
577 URINARY TRACT INFECTION 85 0.0005
578 BLOOD TEST ABNORMAL 7 0.0005
579 DEVICE OCCLUSION 7 0.0005
580 TOOTHACHE 9 0.0005
581 MYASTHENIA GRAVIS 4 0.0005
582 MENTAL IMPAIRMENT 12 0.0005
583 VAGINAL DISCHARGE 5 0.0005
584 SINUS TACHYCARDIA 7 0.0005
585 SUBARACHNOID HAEMORRHAGE 5 0.0005
586 CYTOPENIA 6 0.0005
587 ABNORMAL FAECES 4 0.0005
588 EUPHORIC MOOD 5 0.0005
589 MYELODYSPLASTIC SYNDROME 7 0.0005
590 SPINAL COMPRESSION FRACTURE 4 0.0005
591 FATIGUE 375 0.0005
592 TENDERNESS 5 0.0005
593 INTENTIONAL PRODUCT MISUSE 42 0.0005
594 GASTROENTERITIS 7 0.0005
595 PETECHIAE 5 0.0005
596 INFUSION SITE ERYTHEMA 4 0.0005
597 BLOOD URINE PRESENT 9 0.0005
598 GASTRIC ULCER 9 0.0005
599 SLEEP APNOEA SYNDROME 9 0.0005
600 SYNCOPE 47 0.0005
601 BACK PAIN 108 0.0005
602 ARRHYTHMIA 22 0.0005
603 BLOOD MAGNESIUM DECREASED 4 0.0005
604 PYELONEPHRITIS 4 0.0005
605 ASTHENIA 173 0.0005
606 NAUSEA 363 0.0005
607 RASH MACULAR 16 0.0005
608 URINE OUTPUT DECREASED 4 0.0005
609 CHOLELITHIASIS 15 0.0005
610 ADVERSE DRUG REACTION 41 0.0005
611 GROIN PAIN 4 0.0005
612 TUMOUR LYSIS SYNDROME 4 0.0005
613 SARS-COV-2 TEST POSITIVE 6 0.0005
614 HYPERSOMNIA 13 0.0005
615 FLUID RETENTION 23 0.0005
616 PURPURA 4 0.0005
617 ACUTE MYELOID LEUKAEMIA 7 0.0004
618 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
619 WEIGHT DECREASED 125 0.0004
620 HAEMOLYTIC ANAEMIA 4 0.0004
621 FEEDING DISORDER 9 0.0004
622 HYPOTENSION 89 0.0004
623 PELVIC PAIN 8 0.0004
624 HYPERGLYCAEMIA 16 0.0004
625 DIZZINESS 219 0.0004
626 ACUTE HEPATIC FAILURE 6 0.0004
627 SKIN LESION 12 0.0004
628 PRODUCT USE ISSUE 82 0.0004
629 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
630 SKIN DISCOLOURATION 20 0.0004
631 NEOPLASM 5 0.0004
632 ENCEPHALITIS 3 0.0004
633 RHINORRHOEA 28 0.0004
634 DEMENTIA 12 0.0004
635 HYPERKALAEMIA 15 0.0004
636 HALLUCINATION 32 0.0004
637 PHOTOSENSITIVITY REACTION 7 0.0004
638 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
639 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
640 SPINAL DISORDER 4 0.0004
641 ATAXIA 5 0.0004
642 DEAFNESS 11 0.0004
643 BRONCHOSPASM 6 0.0004
644 CHOLECYSTITIS 5 0.0004
645 BLOOD PRESSURE INCREASED 64 0.0004
646 DYSKINESIA 17 0.0004
647 ACUTE RESPIRATORY FAILURE 8 0.0004
648 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
649 INFLUENZA 46 0.0004
650 FLUID OVERLOAD 6 0.0004
651 CIRCULATORY COLLAPSE 7 0.0004
652 OROPHARYNGEAL PAIN 38 0.0004
653 PARKINSONISM 4 0.0004
654 CEREBRAL INFARCTION 10 0.0004
655 ANAEMIA 78 0.0004
656 MELAENA 9 0.0004
657 VITREOUS FLOATERS 4 0.0004
658 MUSCULOSKELETAL DISCOMFORT 7 0.0004
659 RASH MACULO-PAPULAR 9 0.0004
660 CATARACT 24 0.0004
661 PULMONARY MASS 6 0.0004
662 ILEUS 5 0.0004
663 TOOTH EXTRACTION 5 0.0004
664 RASH PAPULAR 9 0.0004
665 SECRETION DISCHARGE 5 0.0004
666 ANAPHYLACTIC REACTION 22 0.0004
667 COLD SWEAT 7 0.0004
668 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
669 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
670 DRUG ERUPTION 7 0.0004
671 BALANCE DISORDER 34 0.0004
672 TOOTH ABSCESS 4 0.0004
673 ACIDOSIS 3 0.0004
674 DRUG INTERACTION 62 0.0004
675 MUSCLE TWITCHING 9 0.0004
676 PHARYNGEAL OEDEMA 6 0.0004
677 NEUTROPENIA 53 0.0004
678 SOMNOLENCE 78 0.0004
679 SKIN ULCER 10 0.0004
680 DELUSION 6 0.0004
681 HIATUS HERNIA 5 0.0004
682 EJECTION FRACTION DECREASED 6 0.0004
683 SEPSIS 43 0.0004
684 CONSTIPATION 84 0.0004
685 CEREBROVASCULAR ACCIDENT 65 0.0004
686 UNINTENDED PREGNANCY 4 0.0004
687 WEIGHT FLUCTUATION 4 0.0004
688 TRANSFUSION 4 0.0004
689 CYANOSIS 6 0.0004
690 DIARRHOEA 246 0.0004
691 PRODUCT USE COMPLAINT 6 0.0004
692 AGGRESSION 19 0.0004
693 IMMUNE SYSTEM DISORDER 5 0.0004
694 PRODUCT PRESCRIBING ERROR 9 0.0004
695 INFLUENZA LIKE ILLNESS 31 0.0004
696 PRURITUS 144 0.0004
697 MUSCLE TIGHTNESS 6 0.0004
698 DYSPHAGIA 35 0.0004
699 DECUBITUS ULCER 3 0.0004
700 TACHYPNOEA 5 0.0004
701 HYPERTENSIVE CRISIS 4 0.0004
702 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
703 HAEMOPTYSIS 10 0.0004
704 PANIC ATTACK 13 0.0004
705 PRODUCTIVE COUGH 17 0.0004
706 ABDOMINAL PAIN LOWER 9 0.0004
707 RASH ERYTHEMATOUS 17 0.0004
708 HAEMATEMESIS 9 0.0004
709 MITRAL VALVE INCOMPETENCE 4 0.0004
710 PAIN IN JAW 10 0.0004
711 MYOCARDIAL ISCHAEMIA 4 0.0004
712 BRONCHITIS 26 0.0004
713 HEAD INJURY 11 0.0003
714 METASTASES TO LUNG 4 0.0003
715 RESPIRATORY TRACT INFECTION 9 0.0003
716 PLEURAL EFFUSION 21 0.0003
717 SEPTIC SHOCK 15 0.0003
718 BURNING SENSATION 24 0.0003
719 HIP FRACTURE 11 0.0003
720 COVID-19 60 0.0003
721 HYPOXIA 12 0.0003
722 LABORATORY TEST ABNORMAL 10 0.0003
723 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
724 COVID-19 PNEUMONIA 4 0.0003
725 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
726 PSORIASIS 44 0.0003
727 PULMONARY HYPERTENSION 7 0.0003
728 THIRST 6 0.0003
729 POLLAKIURIA 14 0.0003
730 MACULAR DEGENERATION 4 0.0003
731 EPISTAXIS 25 0.0003
732 WRIST FRACTURE 4 0.0003
733 RENAL IMPAIRMENT 28 0.0003
734 HEART RATE INCREASED 33 0.0003
735 CORONARY ARTERY DISEASE 10 0.0003
736 HYPOGLYCAEMIA 16 0.0003
737 NOCTURIA 4 0.0003
738 JOINT INJURY 7 0.0003
739 DRUG DISPENSING ERROR 5 0.0003
740 SKIN CANCER 7 0.0003
741 SMALL INTESTINAL OBSTRUCTION 4 0.0003
742 DEVICE RELATED INFECTION 5 0.0003
743 COUGH 91 0.0003
744 TENDON RUPTURE 4 0.0003
745 NASAL CONGESTION 19 0.0003
746 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
747 TENDONITIS 5 0.0003
748 BACTERIAL INFECTION 6 0.0003
749 HAIR COLOUR CHANGES 4 0.0003
750 DEFORMITY 3 0.0003
751 DIARRHOEA HAEMORRHAGIC 3 0.0003
752 PNEUMONIA ASPIRATION 8 0.0003
753 NEUTROPHIL COUNT DECREASED 13 0.0003
754 OFF LABEL USE 279 0.0003
755 ANGIOEDEMA 14 0.0003
756 STEVENS-JOHNSON SYNDROME 7 0.0003
757 VISUAL IMPAIRMENT 39 0.0003
758 ULCER 5 0.0003
759 MULTIPLE SCLEROSIS 15 0.0003
760 HYPOTHYROIDISM 10 0.0003
761 HYPOPHAGIA 8 0.0003
762 POST PROCEDURAL COMPLICATION 6 0.0003
763 MYALGIA 53 0.0003
764 HEART RATE IRREGULAR 7 0.0003
765 BLOOD POTASSIUM INCREASED 5 0.0003
766 PRODUCT AVAILABILITY ISSUE 7 0.0003
767 KIDNEY INFECTION 6 0.0003
768 SPEECH DISORDER 16 0.0003
769 ANKYLOSING SPONDYLITIS 4 0.0003
770 ABNORMAL BEHAVIOUR 12 0.0003
771 DEPRESSED MOOD 16 0.0003
772 VIRAL INFECTION 10 0.0003
773 BRAIN INJURY 3 0.0003
774 BLOOD UREA INCREASED 5 0.0003
775 QUALITY OF LIFE DECREASED 4 0.0003
776 LOSS OF CONSCIOUSNESS 38 0.0003
777 CANDIDA INFECTION 5 0.0003
778 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
779 DRY THROAT 3 0.0003
780 UVEITIS 4 0.0003
781 DYSPNOEA EXERTIONAL 11 0.0003
782 PLATELET COUNT DECREASED 31 0.0003
783 DYSPHONIA 17 0.0003
784 RESPIRATORY ARREST 8 0.0003
785 LOCALISED INFECTION 7 0.0003
786 ORAL DISCOMFORT 4 0.0003
787 OVERDOSE 62 0.0003
788 HUNGER 4 0.0003
789 METASTASES TO LIVER 5 0.0003
790 HALLUCINATION, VISUAL 6 0.0003
791 BLINDNESS UNILATERAL 4 0.0003
792 BODY HEIGHT DECREASED 3 0.0003
793 DRY EYE 14 0.0003
794 GALLBLADDER DISORDER 5 0.0003
795 LEUKOPENIA 14 0.0003
796 CARDIOGENIC SHOCK 4 0.0003
797 HERPES ZOSTER 16 0.0003
798 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
799 FAECES DISCOLOURED 6 0.0003
800 DRUG ABUSE 23 0.0003
801 LEUKOCYTOSIS 5 0.0003
802 MENTAL DISORDER 12 0.0003
803 RESTLESS LEGS SYNDROME 5 0.0003
804 BONE DISORDER 5 0.0003
805 FUNGAL INFECTION 9 0.0003
806 HEPATOTOXICITY 6 0.0003
807 PANCYTOPENIA 15 0.0003
808 ACUTE KIDNEY INJURY 41 0.0003
809 HAEMORRHAGE INTRACRANIAL 4 0.0003
810 GASTRITIS 7 0.0003
811 BLOOD SODIUM DECREASED 5 0.0003
812 RHABDOMYOLYSIS 11 0.0003
813 FOOT FRACTURE 5 0.0003
814 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
815 ERYTHEMA 54 0.0003
816 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
817 RESPIRATORY FAILURE 19 0.0003
818 JAUNDICE 7 0.0003
819 LIMB INJURY 7 0.0003
820 CAESAREAN SECTION 3 0.0003
821 MENORRHAGIA 5 0.0003
822 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
823 BACTERAEMIA 3 0.0003
824 DISORIENTATION 10 0.0003
825 PNEUMOTHORAX 4 0.0003
826 COMA 12 0.0003
827 BLOOD PRESSURE ABNORMAL 5 0.0003
828 BLOOD PRESSURE FLUCTUATION 6 0.0002
829 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
830 PRESYNCOPE 6 0.0002
831 TREMOR 40 0.0002
832 BLOOD PRESSURE DECREASED 16 0.0002
833 CYTOMEGALOVIRUS INFECTION 4 0.0002
834 COAGULOPATHY 4 0.0002
835 RASH PRURITIC 13 0.0002
836 HAEMORRHAGE 25 0.0002
837 DERMATITIS ALLERGIC 3 0.0002
838 PRODUCT COMPLAINT 6 0.0002
839 CARDIAC FAILURE 19 0.0002
840 RENAL FAILURE ACUTE 10 0.0002
841 PARANOIA 4 0.0002
842 RASH GENERALISED 6 0.0002
843 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
844 EYE PAIN 13 0.0002
845 BLOOD CREATININE INCREASED 15 0.0002
846 MUCOSAL INFLAMMATION 6 0.0002
847 EOSINOPHILIA 4 0.0002
848 DRUG ADMINISTRATION ERROR 7 0.0002
849 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
850 TRANSAMINASES INCREASED 5 0.0002
851 TOOTH DISORDER 5 0.0002
852 ORAL PAIN 5 0.0002
853 BLOOD BILIRUBIN INCREASED 6 0.0002
854 PRODUCT QUALITY ISSUE 30 0.0002
855 SUICIDAL IDEATION 20 0.0002
856 RESPIRATORY DISTRESS 6 0.0002
857 BLOOD GLUCOSE ABNORMAL 4 0.0002
858 PROCEDURAL PAIN 6 0.0002
859 CONJUNCTIVITIS 4 0.0002
860 APHONIA 3 0.0002
861 THERAPEUTIC RESPONSE DECREASED 13 0.0002
862 CARDIAC DISORDER 20 0.0002
863 TARDIVE DYSKINESIA 6 0.0002
864 VISION BLURRED 29 0.0002
865 VISUAL ACUITY REDUCED 7 0.0002
866 PROTEINURIA 4 0.0002
867 MUSCULOSKELETAL DISORDER 4 0.0002
868 CONVULSION 12 0.0002
869 FEELING ABNORMAL 50 0.0002
870 GLAUCOMA 4 0.0002
871 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
872 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
873 UNDERDOSE 15 0.0002
874 AGITATION 15 0.0002
875 DISTURBANCE IN ATTENTION 11 0.0002
876 PSYCHOTIC DISORDER 6 0.0002
877 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
878 ABASIA 5 0.0002
879 OSTEONECROSIS OF JAW 5 0.0002
880 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
881 SKIN EXFOLIATION 17 0.0002
882 TREATMENT NONCOMPLIANCE 11 0.0002
883 UPPER LIMB FRACTURE 4 0.0002
884 SWELLING FACE 13 0.0002
885 SEIZURE 23 0.0002
886 PRODUCT ADHESION ISSUE 7 0.0002
887 ANKLE FRACTURE 3 0.0002
888 RENAL DISORDER 9 0.0002
889 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
890 DRUG INEFFECTIVE 251 0.0002
891 DISEASE RECURRENCE 9 0.0002
892 BRADYCARDIA 10 0.0002
893 INCORRECT DOSE ADMINISTERED 43 0.0002
894 SURGERY 11 0.0002
895 FLUSHING 19 0.0002
896 HOT FLUSH 14 0.0002
897 INTESTINAL OBSTRUCTION 7 0.0002
898 PAIN OF SKIN 5 0.0002
899 PRURITUS GENERALISED 4 0.0002
900 ACNE 14 0.0002
901 DIABETES MELLITUS 14 0.0002
902 CARDIAC ARREST 15 0.0002
903 LIP SWELLING 6 0.0002
904 THROMBOSIS 14 0.0002
905 DYSSTASIA 5 0.0002
906 HEART RATE DECREASED 6 0.0002
907 LYMPHADENOPATHY 6 0.0002
908 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
909 CEREBRAL HAEMORRHAGE 6 0.0002
910 IRRITABILITY 10 0.0002
911 ADVERSE EVENT 15 0.0002
912 EMOTIONAL DISORDER 5 0.0002
913 GYNAECOMASTIA 5 0.0002
914 VAGINAL HAEMORRHAGE 7 0.0002
915 HEPATIC FUNCTION ABNORMAL 6 0.0002
916 DRUG PRESCRIBING ERROR 3 0.0002
917 BLOOD GLUCOSE INCREASED 29 0.0002
918 OSTEONECROSIS 5 0.0002
919 DISEASE PROGRESSION 18 0.0002
920 SKIN DISORDER 5 0.0001
921 FEAR 4 0.0001
922 BONE MARROW FAILURE 3 0.0001
923 NEUROPATHY PERIPHERAL 14 0.0001
924 GASTRIC DISORDER 5 0.0001
925 ABNORMAL DREAMS 4 0.0001
926 INTERSTITIAL LUNG DISEASE 7 0.0001
927 NEOPLASM PROGRESSION 5 0.0001
928 DERMATITIS 3 0.0001
929 RENAL FAILURE 19 0.0001
930 FLATULENCE 8 0.0001
931 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
932 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
933 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
934 THROAT IRRITATION 6 0.0001
935 BLOOD POTASSIUM DECREASED 4 0.0001
936 LACRIMATION INCREASED 4 0.0001
937 MYOCARDIAL INFARCTION 23 0.0001
938 PLASMA CELL MYELOMA 5 0.0001
939 METABOLIC ACIDOSIS 4 0.0001
940 BLOOD GLUCOSE DECREASED 6 0.0001
941 EYE DISORDER 4 0.0001
942 STAPHYLOCOCCAL INFECTION 4 0.0001
943 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
944 AGEUSIA 3 0.0001
945 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
946 ANGER 4 0.0001
947 CARDIOVASCULAR DISORDER 3 0.0001
948 BREAST CANCER 11 0.0001
949 ILLNESS 12 0.0001
950 ANAPHYLACTIC SHOCK 3 0.0001
951 EMOTIONAL DISTRESS 14 0.0001
952 DEVICE DISLOCATION 5 0.0001
953 ANHEDONIA 3 0.0001
954 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
955 MYELOSUPPRESSION 4 0.0001
956 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
957 HOSPITALISATION 17 0.0001
958 DRUG EFFECT INCOMPLETE 4 0.0001
959 OCULAR HYPERAEMIA 5 0.0001
960 CARDIAC FAILURE CONGESTIVE 8 0.0001
961 DEVICE BREAKAGE 4 0.0001
962 BLINDNESS 4 0.0001
963 BONE DENSITY DECREASED 3 0.0001
964 UNEVALUABLE EVENT 7 0.0001
965 DEVICE LEAKAGE 4 0.0001
966 PRODUCT DOSE OMISSION ISSUE 27 0.0001
967 INJECTION SITE BRUISING 7 0.0001
968 INJECTION SITE HAEMORRHAGE 7 0.0001
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
971 CRYING 3 0.0001
972 DRY SKIN 11 0.0001
973 DRUG WITHDRAWAL SYNDROME 7 0.0001
974 DRUG DOSE OMISSION 13 0.0001
975 TOXICITY TO VARIOUS AGENTS 13 0.0001
976 PRODUCT DOSE OMISSION 5 0.0001
977 NEOPLASM MALIGNANT 5 0.0001
978 PROSTATE CANCER 6 0.0001
979 DRUG EFFECT DECREASED 4 0.0001
980 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
981 CARDIO-RESPIRATORY ARREST 3 0.0001
982 DEATH 61 0.0001
983 EYE IRRITATION 4 0.0001
984 DEVICE ISSUE 6 0.0001
985 INJECTION SITE PAIN 20 0.0001
986 SKIN BURNING SENSATION 4 0.0001
987 INJECTION SITE SWELLING 4 0.0001
988 NO ADVERSE EVENT 9 0.0000
989 DEVICE DIFFICULT TO USE 3 0.0000
990 DEVICE MALFUNCTION 3 0.0000
991 DRUG DEPENDENCE 4 0.0000